The Royal Marsden NHS Foundation Trust, London, UK.
Curr Opin Support Palliat Care. 2013 Jun;7(2):144-52. doi: 10.1097/SPC.0b013e328360b09e.
Persistent postsurgical pain (PPP) is an important cause of pain morbidity following surgery for almost any cause, but there is a greater evidence base for pain after cancer surgery. Historically, both patients and practitioners have struggled to recognize and accept this growing problem. This review will seek to highlight the awareness of this increasing epidemic and will discuss evidence base for diagnosis, risk factors and current strategies for prevention and treatment, especially after cancer surgery.
Given the potential size of the problems of PPP, there is a relative paucity of recent data, especially as regards effective treatments. The review will synthesize current and existing evidence to give a balanced up-to-date view. There is a clear need for more high-quality randomized trials.
An estimated 40,000 patients in the UK will develop PPP, of whom at least 5-10% will have severe pain. Lack of clear definition and lack of awareness have been barriers to diagnosis and access to treatment. Several risk factors associated with PPP have been identified and reduction of these factors may prevent its development. At present, there are large gaps in the evidence base and more large controlled trials are warranted.
持续性手术后疼痛(PPP)是几乎任何原因手术后疼痛发病率的重要原因,但癌症手术后疼痛的证据基础更为充分。历史上,患者和医生都难以认识和接受这一日益严重的问题。本综述将强调对这一不断增加的流行疾病的认识,并讨论诊断、风险因素以及目前预防和治疗策略的证据基础,尤其是癌症手术后的策略。
鉴于 PPP 问题的潜在规模,最近的数据相对较少,尤其是关于有效治疗的。该综述将综合当前和现有证据,给出一个平衡的最新观点。显然需要更多高质量的随机试验。
英国估计有 40000 名患者会出现 PPP,其中至少有 5-10%会有严重疼痛。缺乏明确的定义和意识是诊断和治疗的障碍。已经确定了几个与 PPP 相关的风险因素,减少这些因素可能预防其发展。目前,证据基础存在很大差距,需要进行更多的大型对照试验。